Paramount Speciality Forgings PSFL H2 FY26 Concall Decoded: The Expansion Bet Versus Three Straight Years of Stalled Topline

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1. Opening Hook

For three years, PSFL’s topline moved like a rusted flange. ₹110 cr (FY23), ₹113 cr (FY24), ₹110 cr (FY25), ₹120 cr (FY26)—the company flatlined while management blamed the equipment. Now it’s swung a hammer. A 10-ton forging hammer, a 2,000-ton press, and a lab. Management reckons H1 FY27 brings trials; H2 brings the picture. Until then, the ₹120 cr earned in a quarter is the only fact. Everything else is a promise wrapped in a capex bill.

2. At a Glance

• FY26 Revenue: ₹120 cr, up ~9% YoY; Q4 FY26 at ₹62 cr, flat to prior quarter.
• FY26 Profit: ₹4.3 cr (down from ₹4.4 cr in FY25); Q4 profit ₹2.1 cr, down 28% QoQ.
• Operating Margin: 6.2% full year; Q4 at 6.4%—compression from the 8% seen in FY25.
• Capex committed: ₹23–24 cr for Kalapur expansion (10-ton hammer, 2,000-ton press, trim press, ancillary).
• Stated FY27 target: ₹150–160 cr revenue; management promises H2 visibility, not H1.
• EBITDA aspiration: “14–15% reasonably good” long-run; near-term H2 FY27 guided as “~8–10%.”
• Order book: ₹45–50 cr, down from ₹57.5 cr (Mar 2025); executable in 3–5 months.

3. Management’s Key Commentary

On legacy bottlenecks:
“The old plant… breakages, outages… disruptions.”
(Translation: The equipment is old enough to have its own depreciation schedule.)

On the 10-ton hammer’s role:
“Capable of doing more work than three equipments.”
(Translation: Presently competing with one equipment at a time, losing orders because of it.)

On expansion timeline:
“Complete the entire trials within H1… However, H2 will give us a better picture as far as revenue and output.”
(Translation: H1 is the warm-up lap. The race starts in October.)

On the in-house lab:
“Creates another business avenue to carry out testing for other companies as well.”
(Translation: A lab that also sells lab services, applied for accreditation in Feb, expected “in a couple of months”—we’ll revisit this in Q1.)

On export margins:
“Margins a little bit lesser than domestic… but payment cycles are better with exports.”
(Translation: Lower gross profit per rupee; better working capital theater.)

On long-run revenue potential:
“Maximum revenue potential can run up to between 150 to 300 crores.”
(Translation: A range so wide it could fit a 2,000-ton press sideways. ₹150 cr is FY27 target; ₹300 cr is the dream scenario.)

On Reliance as largest customer:
“Reliance is our biggest customer at the moment… across projects including Dahej, Nagothane, Jamnagar… and even Reliance’s solar.”
(Translation: Customer concentration at the top; solar is their new push, and PSFL is along for the ride.)

4. Numbers Decoded

The compression story:
Revenue rose 9%, but operating profit margin fell 180 bps and net profit fell 5%. Input costs outran pricing. The company ran its existing plants harder—55% utilization achieved via efficiency grabs—but profitability didn’t tag along. Capex is now a